Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-03

Clinical Trial Update: To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin [Phase 2]

View source ↗

Summary

Phase 2 trial investigating FOL-005 for hair growth in androgenic alopecia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOL-005

Snippet

Sponsor: Follicum AB | Conditions: Androgenic Alopecia | Phase 2 | Status: COMPLETED | Results posted: 2020-12-03